These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28411643)

  • 1. Transgultaminase-Mediated Nanoarmoring of Enzymes by PEGylation.
    Grigoletto A; Mero A; Maso K; Pasut G
    Methods Enzymol; 2017; 590():317-346. PubMed ID: 28411643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new method to increase selectivity of transglutaminase mediated PEGylation of salmon calcitonin and human growth hormone.
    Mero A; Schiavon M; Veronese FM; Pasut G
    J Control Release; 2011 Aug; 154(1):27-34. PubMed ID: 21565230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical and enzymatic site specific PEGylation of hGH.
    da Silva Freitas D; Mero A; Pasut G
    Bioconjug Chem; 2013 Mar; 24(3):456-63. PubMed ID: 23432141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-specific modification and PEGylation of pharmaceutical proteins mediated by transglutaminase.
    Fontana A; Spolaore B; Mero A; Veronese FM
    Adv Drug Deliv Rev; 2008 Jan; 60(1):13-28. PubMed ID: 17916398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covalent immobilisation of transglutaminase: stability and applications in protein PEGylation.
    Grigoletto A; Mero A; Yoshioka H; Schiavon O; Pasut G
    J Drug Target; 2017; 25(9-10):856-864. PubMed ID: 28805084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intense PEGylation of Enzyme Surfaces: Relevant Stabilizing Effects.
    Moreno-Pérez S; Orrego AH; Romero-Fernández M; Trobo-Maseda L; Martins-DeOliveira S; Munilla R; Fernández-Lorente G; Guisan JM
    Methods Enzymol; 2016; 571():55-72. PubMed ID: 27112394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PEG - a versatile conjugating ligand for drugs and drug delivery systems.
    Kolate A; Baradia D; Patil S; Vhora I; Kore G; Misra A
    J Control Release; 2014 Oct; 192():67-81. PubMed ID: 24997275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new site-specific monoPEGylated filgrastim derivative prepared by enzymatic conjugation: Production and physicochemical characterization.
    Scaramuzza S; Tonon G; Olianas A; Messana I; Schrepfer R; Orsini G; Caliceti P
    J Control Release; 2012 Dec; 164(3):355-63. PubMed ID: 22735238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical and Enzymatic Site Specific PEGylation of hGH: The Stability and in vivo Activity of PEG-N-Terminal-hGH and PEG-Gln141-hGH Conjugates.
    Grigoletto A; Mero A; Zanusso I; Schiavon O; Pasut G
    Macromol Biosci; 2016 Jan; 16(1):50-6. PubMed ID: 26350165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of PEGylation on biological therapies.
    Veronese FM; Mero A
    BioDrugs; 2008; 22(5):315-29. PubMed ID: 18778113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transglutaminase-mediated PEGylation of proteins: direct identification of the sites of protein modification by mass spectrometry using a novel monodisperse PEG.
    Mero A; Spolaore B; Veronese FM; Fontana A
    Bioconjug Chem; 2009 Feb; 20(2):384-9. PubMed ID: 19186937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-level expression of a recombinant active microbial transglutaminase in Escherichia coli.
    Salis B; Spinetti G; Scaramuzza S; Bossi M; Saccani Jotti G; Tonon G; Crobu D; Schrepfer R
    BMC Biotechnol; 2015 Sep; 15():84. PubMed ID: 26369939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-directed enzymatic PEGylation of the human granulocyte colony-stimulating factor.
    Maullu C; Raimondo D; Caboi F; Giorgetti A; Sergi M; Valentini M; Tonon G; Tramontano A
    FEBS J; 2009 Nov; 276(22):6741-50. PubMed ID: 19843182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEGylation of native disulfide bonds in proteins.
    Brocchini S; Balan S; Godwin A; Choi JW; Zloh M; Shaunak S
    Nat Protoc; 2006; 1(5):2241-52. PubMed ID: 17406463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of site-specific ScFv PEGylation for tumor-targeting pharmaceuticals.
    Natarajan A; Xiong CY; Albrecht H; DeNardo GL; DeNardo SJ
    Bioconjug Chem; 2005; 16(1):113-21. PubMed ID: 15656582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation, characterization and molecular modeling of PEGylated human growth hormone with agonist activity.
    Khameneh B; Jaafari MR; Hassanzadeh-Khayyat M; Varasteh A; Chamani J; Iranshahi M; Mohammadpanah H; Abnous K; Saberi MR
    Int J Biol Macromol; 2015 Sep; 80():400-9. PubMed ID: 26116386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Covalent conjugation of poly(ethylene glycol) to proteins and peptides: strategies and methods.
    Mero A; Clementi C; Veronese FM; Pasut G
    Methods Mol Biol; 2011; 751():95-129. PubMed ID: 21674328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEGylation: an approach for drug delivery. A review.
    Jain A; Jain SK
    Crit Rev Ther Drug Carrier Syst; 2008; 25(5):403-47. PubMed ID: 19062633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PEGylation and its impact on the design of new protein-based medicines.
    Ginn C; Khalili H; Lever R; Brocchini S
    Future Med Chem; 2014; 6(16):1829-46. PubMed ID: 25407370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyethylene Glycol Based Changes to β-Sheet Protein Conformational and Proteolytic Stability Depend on Conjugation Strategy and Location.
    Draper SRE; Lawrence PB; Billings WM; Xiao Q; Brown NP; Bécar NA; Matheson DJ; Stephens AR; Price JL
    Bioconjug Chem; 2017 Oct; 28(10):2507-2513. PubMed ID: 28972368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.